{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:18:26Z","timestamp":1788358706945,"version":"build-2803163510"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Health","award":["R25 CA225513"],"award-info":[{"award-number":["R25 CA225513"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS125175-01A1"],"award-info":[{"award-number":["K08NS125175-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children\u2019s Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002564","name":"Alternatives Research and Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Defense, Rare Cancer Research Program","award":["RA210290"],"award-info":[{"award-number":["RA210290"]}]},{"DOI":"10.13039\/100003517","name":"Wipe Out Kids\u2019 Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003517","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Margaret E Early Medical Research Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13346-026-02164-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:15:40Z","timestamp":1781694940000},"page":"3231-3257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding DMG: current treatment options and prospective solutions using nanoparticles"],"prefix":"10.1007","volume":"16","author":[{"given":"Ahmed","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey","family":"Lyzlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex A.","family":"Moats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Margol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Upreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"6","key":"2164_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/CCO.0000000000000577","volume":"31","author":"R Aziz-Bose","year":"2019","unstructured":"Aziz-Bose R, Monje M. Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets. Curr Opin Oncol. 2019;31(6):522\u201330.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"2164_CR2","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.ijrobp.2012.09.004","volume":"85","author":"KA Bradley","year":"2013","unstructured":"Bradley KA, Zhou T, McNall-Knapp RY, Jakacki RI, Levy AS, Vezina G, et al. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children\u2019s oncology group phase 2 study. Int J Radiat Oncol Biol Phys. 2013;85(1):e55\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2164_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","volume":"19","author":"T Cooney","year":"2017","unstructured":"Cooney T, Lane A, Bartels U, Bouffet E, Goldman S, Leary SES, et al. Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study. Neuro-oncology. 2017;19(9):1279\u201380.","journal-title":"Neuro-oncology"},{"issue":"19","key":"2164_CR4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, et al. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018;36(19):1963\u201372.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"2164_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/14737140.2015.974563","volume":"15","author":"SE Veldhuijzen van Zanten","year":"2015","unstructured":"Veldhuijzen van Zanten SE, Jansen MH, Sanchez Aliaga E, van Vuurden DG, Vandertop WP, Kaspers GJ. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands. Expert Rev Anticancer Ther. 2015;15(2):157\u201364.","journal-title":"Expert Rev Anticancer Ther"},{"key":"2164_CR6","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.neo.2022.100851","volume":"35","author":"C Coleman","year":"2023","unstructured":"Coleman C, Chen K, Lu A, Seashore E, Stoller S, Davis T, et al. Interdisciplinary care of children with diffuse midline glioma. Neoplasia. 2023;35:100851.","journal-title":"Neoplasia"},{"issue":"7","key":"2164_CR7","first-page":"1569","volume":"89","author":"PG Fisher","year":"2000","unstructured":"Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, et al. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer. 2000;89(7):1569\u201376.","journal-title":"Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer"},{"key":"2164_CR8","doi-asserted-by":"publisher","first-page":"1152430","DOI":"10.3389\/fnmol.2023.1152430","volume":"16","author":"L De Martino","year":"2023","unstructured":"De Martino L, Picariello S, Russo C, Errico ME, Spennato P, Papa MR, et al. Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review. Front Mol Neurosci. 2023;16:1152430.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"2164_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3892\/ol.2023.14181","volume":"27","author":"X Ge","year":"2024","unstructured":"Ge X, Yang Y, Wang W, Tian L, Zhang G, Tian Z, et al. Pediatric H3K27M\u2011mutant diffuse midline glioma with vertebral metastasis: A case report and literature review. Oncol Lett. 2024;27(2):48.","journal-title":"Oncol Lett"},{"issue":"1","key":"2164_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00381-025-06903-4","volume":"41","author":"AM Giantini-Larsen","year":"2025","unstructured":"Giantini-Larsen AM, Garton ALA, Rivera M, Han R, Pisapia DJ, Sait SF, et al. Diffuse midline glioma with extra central nervous system metastases in the pediatric, adolescent, and young adult population. Child\u2019s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2025;41(1):306.","journal-title":"Child\u2019s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery"},{"issue":"4","key":"2164_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00401-014-1319-6","volume":"128","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta neuropathologica. 2014;128(4):573\u201381.","journal-title":"Acta neuropathologica"},{"issue":"4","key":"2164_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-014-1307-x","volume":"128","author":"V Caretti","year":"2014","unstructured":"Caretti V, Bugiani M, Freret M, Schellen P, Jansen M, van Vuurden D, et al. Subventricular spread of diffuse intrinsic pontine glioma. Acta neuropathologica. 2014;128(4):605\u20137.","journal-title":"Acta neuropathologica"},{"issue":"3","key":"2164_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta neuropathologica. 2012;124(3):439\u201347.","journal-title":"Acta neuropathologica"},{"issue":"7384","key":"2164_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482(7384):226\u201331.","journal-title":"Nature"},{"issue":"9","key":"2164_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","volume":"27","author":"KM Chan","year":"2013","unstructured":"Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev. 2013;27(9):985\u201390.","journal-title":"Genes Dev"},{"issue":"4","key":"2164_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41388-021-02102-y","volume":"41","author":"IJ Findlay","year":"2022","unstructured":"Findlay IJ, De Iuliis GN, Duchatel RJ, Jackson ER, Vitanza NA, Cain JE, et al. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies. Oncogene. 2022;41(4):461\u201375.","journal-title":"Oncogene"},{"key":"2164_CR17","doi-asserted-by":"crossref","unstructured":"Nikolaev A, Fiveash JB, Yang ES: Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG. Int J Mol Sci 2020, 21(2).","DOI":"10.3390\/ijms21020490"},{"key":"2164_CR18","doi-asserted-by":"publisher","first-page":"858148","DOI":"10.3389\/fonc.2022.858148","volume":"12","author":"HG Vuong","year":"2022","unstructured":"Vuong HG, Ngo TNM, Le HT, Jea A, Hrachova M, Battiste J, et al. Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas. Frontiers in oncology. 2022;12:858148.","journal-title":"Frontiers in oncology"},{"issue":"1","key":"2164_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08823-9","volume":"10","author":"CM Hoeman","year":"2019","unstructured":"Hoeman CM, Cordero FJ, Hu G, Misuraca K, Romero MM, Cardona HJ, et al. ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nature communications. 2019;10(1):1023.","journal-title":"Nature communications"},{"issue":"5","key":"2164_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet. 2014;46(5):462\u20136.","journal-title":"Nat Genet"},{"issue":"4","key":"2164_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, et al. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. Cancer Cell. 2017;32(4):520\u201337.e525.","journal-title":"Cancer Cell"},{"issue":"21\u201322","key":"2164_CR22","doi-asserted-by":"publisher","first-page":"e1800479","DOI":"10.1002\/pmic.201800479","volume":"19","author":"RJ Duchatel","year":"2019","unstructured":"Duchatel RJ, Jackson ER, Alvaro F, Nixon B, Hondermarck H, Dun MD. Signal Transduction in Diffuse Intrinsic Pontine Glioma. Proteomics. 2019;19(21\u201322):e1800479.","journal-title":"Proteomics"},{"issue":"40","key":"2164_CR23","doi-asserted-by":"publisher","first-page":"65696","DOI":"10.18632\/oncotarget.11602","volume":"7","author":"C Koschmann","year":"2016","unstructured":"Koschmann C, Zamler D, MacKay A, Robinson D, Wu YM, Doherty R, et al. Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma. Oncotarget. 2016;7(40):65696\u2013706.","journal-title":"Oncotarget"},{"issue":"4","key":"2164_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ccell.2025.02.018","volume":"43","author":"L Mayr","year":"2025","unstructured":"Mayr L, Neyazi S, Schwark K, Trissal M, Beck A, Labelle J, et al. Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell. 2025;43(4):740\u201356.e748.","journal-title":"Cancer Cell"},{"issue":"1","key":"2164_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28198-8","volume":"13","author":"P Khadka","year":"2022","unstructured":"Khadka P, Reitman ZJ, Lu S, Buchan G, Gionet G, Dubois F, et al. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nature communications. 2022;13(1):604.","journal-title":"Nature communications"},{"issue":"30","key":"2164_CR26","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(30):3999\u20134006.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"8","key":"2164_CR27","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/neuonc\/noaf097","volume":"27","author":"Y Guo","year":"2025","unstructured":"Guo Y, Li Z, Parsels LA, Wang Z, Parsels JD, Dalvi A, et al. H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition. Neuro-oncology. 2025;27(8):2129\u201346.","journal-title":"Neuro-oncology"},{"issue":"12","key":"2164_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.trecan.2024.09.002","volume":"10","author":"A Cassim","year":"2024","unstructured":"Cassim A, Dun MD, Gallego-Ortega D, Valdes-Mora F. EZHIP\u2019s role in diffuse midline glioma: echoes of oncohistones? Trends Cancer. 2024;10(12):1095\u2013105.","journal-title":"Trends Cancer"},{"key":"2164_CR29","doi-asserted-by":"crossref","unstructured":"Bailey CP, Wang R, Figueroa M, Zhang S, Wang L, Chandra J: Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location. Comput Syst Oncol 2021, 1(3).","DOI":"10.1002\/cso2.1016"},{"issue":"1","key":"2164_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","volume":"6","author":"GL Lin","year":"2018","unstructured":"Lin GL, Nagaraja S, Filbin MG, Suva ML, Vogel H, Monje M. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun. 2018;6(1):51.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2164_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/neuonc\/noy145","volume":"21","author":"NAP Lieberman","year":"2019","unstructured":"Lieberman NAP, DeGolier K, Kovar HM, Davis A, Hoglund V, Stevens J, et al. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro-oncology. 2019;21(1):83\u201394.","journal-title":"Neuro-oncology"},{"issue":"9","key":"2164_CR32","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1158\/2326-6066.CIR-18-0939","volume":"7","author":"M Bockmayr","year":"2019","unstructured":"Bockmayr M, Klauschen F, Maire CL, Rutkowski S, Westphal M, Lamszus K, et al. Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas. Cancer Immunol Res. 2019;7(9):1401\u201311.","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"2164_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11940-019-0577-y","volume":"21","author":"NA Vitanza","year":"2019","unstructured":"Vitanza NA, Monje M. Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials. Curr Treat Options Neurol. 2019;21(8):37.","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"2164_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nou104","volume":"17","author":"MH Jansen","year":"2015","unstructured":"Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro-oncology. 2015;17(1):160\u20136.","journal-title":"Neuro-oncology"},{"issue":"1","key":"2164_CR35","first-page":"9","volume":"24","author":"NJ Fischbein","year":"1996","unstructured":"Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatric neurosurgery. 1996;24(1):9\u201323.","journal-title":"Pediatric neurosurgery"},{"issue":"6","key":"2164_CR36","first-page":"1026","volume":"33","author":"AL Albright","year":"1993","unstructured":"Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children\u2019s Cancer Group. Neurosurgery. 1993;33(6):1026\u20139. ; discussion 1029\u20131030","journal-title":"Neurosurgery"},{"key":"2164_CR37","doi-asserted-by":"crossref","unstructured":"Puget S, Blauwblomme T, Grill J: Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma? Am Soc Clin Oncol Educ Book 2012:629-33.","DOI":"10.14694\/EdBook_AM.2012.32.59"},{"issue":"1","key":"2164_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/pbc.25224","volume":"62","author":"ZJ Wang","year":"2015","unstructured":"Wang ZJ, Rao L, Bhambhani K, Miller K, Poulik J, Altinok D, et al. Diffuse intrinsic pontine glioma biopsy: a single institution experience. Pediatr Blood Cancer. 2015;62(1):163\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"2164_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.wneu.2024.06.163","volume":"189","author":"SR Sheikh","year":"2024","unstructured":"Sheikh SR, Patel NJ, Recinos VMR. Safety and Technical Efficacy of Pediatric Brainstem Biopsies: An Updated Meta-Analysis of 1000\u2009+\u2009Children. World Neurosurg. 2024;189:428\u201338.e422.","journal-title":"World Neurosurg"},{"issue":"11","key":"2164_CR40","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/neuonc\/noy070","volume":"20","author":"N Gupta","year":"2018","unstructured":"Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, et al. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro-oncology. 2018;20(11):1547\u201355.","journal-title":"Neuro-oncology"},{"key":"2164_CR41","doi-asserted-by":"crossref","unstructured":"McVeigh L, Patel T, Miclea M, Schwark K, Ajaero D, Momen F, et al: Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma. Cancers (Basel) 2025, 17(6).","DOI":"10.3390\/cancers17060931"},{"key":"2164_CR42","doi-asserted-by":"publisher","first-page":"1504440","DOI":"10.3389\/fonc.2024.1504440","volume":"14","author":"SR Sheikh","year":"2024","unstructured":"Sheikh SR, Recinos VMR, Thompson EM, Mangum R, Wright-Nadkarni M, Gampel B, et al. The role of brainstem biopsy and targeted therapies in pediatric diffuse midline glioma\/diffuse intrinsic pontine glioma. Frontiers in oncology. 2024;14:1504440.","journal-title":"Frontiers in oncology"},{"issue":"8","key":"2164_CR43","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/neuonc\/noac030","volume":"24","author":"E Cantor","year":"2022","unstructured":"Cantor E, Wierzbicki K, Tarapore RS, Ravi K, Thomas C, Cartaxo R, et al. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. Neuro-oncology. 2022;24(8):1366\u201374.","journal-title":"Neuro-oncology"},{"issue":"1","key":"2164_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84513-1","volume":"11","author":"D Li","year":"2021","unstructured":"Li D, Bonner ER, Wierzbicki K, Panditharatna E, Huang T, Lulla R, et al. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR. Scientific reports. 2021;11(1):5098.","journal-title":"Scientific reports"},{"issue":"23","key":"2164_CR45","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1158\/1078-0432.CCR-18-1345","volume":"24","author":"E Panditharatna","year":"2018","unstructured":"Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, et al. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018;24(23):5850\u20139.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"Supplement_2","key":"2164_CR46","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1093\/neuonc\/noad229","volume":"26","author":"J Patel","year":"2024","unstructured":"Patel J, Aittaleb R, Doherty R, Gera A, Lau B, Messinger D, et al. Liquid biopsy in H3K27M diffuse midline glioma. Neuro-oncology. 2024;26(Supplement_2):S101\u2013s109.","journal-title":"Neuro-oncology"},{"key":"2164_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fonc.2018.00239","volume":"8","author":"KE Warren","year":"2018","unstructured":"Warren KE. Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma. Frontiers in oncology. 2018;8:239.","journal-title":"Frontiers in oncology"},{"issue":"4","key":"2164_CR48","doi-asserted-by":"publisher","first-page":"e61512","DOI":"10.1371\/journal.pone.0061512","volume":"8","author":"SJ Veringa","year":"2013","unstructured":"Veringa SJ, Biesmans D, van Vuurden DG, Jansen MH, Wedekind LE, Horsman I, et al. In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma. PLoS One. 2013;8(4):e61512.","journal-title":"PLoS One"},{"issue":"5","key":"2164_CR49","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3171\/jns.2002.96.5.0885","volume":"96","author":"DI Sandberg","year":"2002","unstructured":"Sandberg DI, Edgar MA, Souweidane MM. Convection-enhanced delivery into the rat brainstem. J Neurosurg. 2002;96(5):885\u201391.","journal-title":"J Neurosurg"},{"issue":"4","key":"2164_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/2008.11.PEDS08281","volume":"3","author":"JL Frazier","year":"2009","unstructured":"Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI. Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr. 2009;3(4):259\u201369.","journal-title":"J Neurosurg Pediatr"},{"issue":"5","key":"2164_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40272-013-0033-5","volume":"15","author":"R Kebudi","year":"2013","unstructured":"Kebudi R, Cakir FB. Management of diffuse pontine gliomas in children: recent developments. Paediatr Drugs. 2013;15(5):351\u201362.","journal-title":"Paediatr Drugs"},{"issue":"2","key":"2164_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/jns.1987.66.2.0227","volume":"66","author":"RD Jenkin","year":"1987","unstructured":"Jenkin RD, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, et al. Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. J Neurosurg. 1987;66(2):227\u201333.","journal-title":"J Neurosurg"},{"issue":"6","key":"2164_CR53","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/1097-0142(19940915)74:6<1827::AID-CNCR2820740628>3.0.CO;2-Q","volume":"74","author":"RJ Packer","year":"1994","unstructured":"Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I\/II Trial. Cancer. 1994;74(6):1827\u201334.","journal-title":"Cancer"},{"key":"2164_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","volume":"73","author":"GO Janssens","year":"2017","unstructured":"Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, et al. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group. Eur J Cancer. 2017;73:38\u201347.","journal-title":"Eur J Cancer"},{"issue":"10","key":"2164_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5694\/mja2.52295","volume":"220","author":"S Valvi","year":"2024","unstructured":"Valvi S, Manoharan N, Mateos MK, Hassall TE, Ziegler DS, McCowage GB, et al. Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children\u2019s Haematology\/Oncology Group position statement. Med J Aust. 2024;220(10):533\u20138.","journal-title":"Med J Aust"},{"issue":"4","key":"2164_CR56","doi-asserted-by":"publisher","first-page":"e31587","DOI":"10.1002\/pbc.31587","volume":"72","author":"MS Zaghloul","year":"2025","unstructured":"Zaghloul MS, Bishr MK, Refaat A, Hemaly AE, Ayadi MA, Ahmed S, et al. Re-Irradiation for the Progressive Pediatric Diffuse Intrinsic Pontine Glioma: A Report on 109 Children From a Single Center. Pediatr Blood Cancer. 2025;72(4):e31587.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2164_CR57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0514-2","volume":"14","author":"MI Vanan","year":"2017","unstructured":"Vanan MI, Underhill DA, Eisenstat DD. Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas. Neurotherapeutics. 2017;14(2):274\u201383.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"2164_CR58","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","volume":"43","author":"LR Mandell","year":"1999","unstructured":"Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43(5):959\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2164_CR59","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0959-8049(02)00029-1","volume":"38","author":"F Doz","year":"2002","unstructured":"Doz F, Neuenschwander S, Bouffet E, Gentet JC, Schneider P, Kalifa C, et al. Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique. Eur J Cancer. 2002;38(6):815\u20139.","journal-title":"Eur J Cancer"},{"issue":"4","key":"2164_CR60","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, et al. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group. Neuro-oncology. 2011;13(4):410\u20136.","journal-title":"Neuro-oncology"},{"issue":"1","key":"2164_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-010-0141-9","volume":"100","author":"A Michalski","year":"2010","unstructured":"Michalski A, Bouffet E, Taylor RE, Hargrave D, Walker D, Picton S, et al. The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma. Journal of Neuro-Oncology. 2010;100(1):81\u201388.","journal-title":"Journal of Neuro-Oncology"},{"issue":"3","key":"2164_CR62","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-010-0334-2","volume":"102","author":"JE Wolff","year":"2011","unstructured":"Wolff JE, Kortmann RD, Wolff B, Pietsch T, Peters O, Schmid HJ, et al. High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study. Journal of Neuro-Oncology. 2011;102(3):433\u201342.","journal-title":"Journal of Neuro-Oncology"},{"issue":"3","key":"2164_CR63","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","volume":"4","author":"M Gallitto","year":"2019","unstructured":"Gallitto M, Lazarev S, Wasserman I, Stafford JM, Wolden SL, Terezakis SA, et al. Role of Radiation Therapy in the Management of Diffuse Intrinsic Pontine Glioma: A Systematic Review. Adv Radiat Oncol. 2019;4(3):520\u201331.","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"2164_CR64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-008-9525-5","volume":"87","author":"M Massimino","year":"2008","unstructured":"Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, et al. Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. Journal of Neuro-Oncology. 2008;87(3):355\u201361.","journal-title":"Journal of Neuro-Oncology"},{"issue":"4","key":"2164_CR65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1215\/15228517-2008-025","volume":"10","author":"N Sirachainan","year":"2008","unstructured":"Sirachainan N, Pakakasama S, Visudithbhan A, Chiamchanya S, Tuntiyatorn L, Dhanachai M, et al. Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma. Neuro-Oncology. 2008;10(4):577\u201382.","journal-title":"Neuro-Oncology"},{"key":"2164_CR66","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3390\/diagnostics12092064","volume":"12","author":"V Di Ruscio","year":"2022","unstructured":"Di Ruscio V, Del Baldo G, Fabozzi F, Vinci M, Cacchione A, de Billy E, et al. Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle. Diagnostics (Basel). 2022;12:2064.","journal-title":"Diagnostics (Basel)"},{"issue":"18","key":"2164_CR67","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.ejca.2013.08.006","volume":"49","author":"S Bailey","year":"2013","unstructured":"Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy\u2013results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer. 2013;49(18):3856\u201362.","journal-title":"Eur J Cancer"},{"issue":"12","key":"2164_CR68","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/cncr.21593","volume":"104","author":"TJ MacDonald","year":"2005","unstructured":"MacDonald TJ, Arenson EB, Ater J, Sposto R, Bevan HE, Bruner J, et al. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children\u2019s Cancer Group Study 9933. Cancer. 2005;104(12):2862\u201371.","journal-title":"Cancer"},{"issue":"1","key":"2164_CR69","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1200\/JCO.1995.13.1.112","volume":"13","author":"JL Finlay","year":"1995","unstructured":"Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. Journal of Clinical Oncology. 1995;13(1):112\u201323.","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"2164_CR70","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2018.10.PEDS18377","volume":"23","author":"IF Pollack","year":"2019","unstructured":"Pollack IF, Agnihotri S, Broniscer A. Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr. 2019;23(3):261\u201373.","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"2164_CR71","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/neuonc\/noq202","volume":"13","author":"DA Haas-Kogan","year":"2011","unstructured":"Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, et al. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro-Oncology. 2011;13(3):298\u2013306.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"2164_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","volume":"38","author":"MH Jansen","year":"2012","unstructured":"Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev. 2012;38(1):27\u201335.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2164_CR73","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","volume":"22","author":"VV Prabhu","year":"2020","unstructured":"Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, et al. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia. 2020;22(12):725\u201344.","journal-title":"Neoplasia"},{"key":"2164_CR74","doi-asserted-by":"publisher","first-page":"e170329","DOI":"10.1172\/JCI170329","volume":"134","author":"RJ Duchatel","year":"2024","unstructured":"Duchatel RJ, Jackson ER, Parackal SG, Kiltschewskij D, Findlay IJ, Mannan A, et al. PI3K\/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma. J Clin Invest. 2024;134:e170329.","journal-title":"J Clin Invest"},{"issue":"7903","key":"2164_CR75","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. 2022;603(7903):934\u201341.","journal-title":"Nature"},{"issue":"1","key":"2164_CR76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/2159-8290.CD-22-0750","volume":"13","author":"NA Vitanza","year":"2023","unstructured":"Vitanza NA, Wilson AL, Huang W, Seidel K, Brown C, Gustafson JA, et al. Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. Cancer Discov. 2023;13(1):114\u201331.","journal-title":"Cancer Discov"},{"issue":"26","key":"2164_CR77","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","volume":"375","author":"CE Brown","year":"2016","unstructured":"Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, et al. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. N Engl J Med. 2016;375(26):2561\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"2164_CR78","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","volume":"31","author":"NA Vitanza","year":"2025","unstructured":"Vitanza NA, Ronsley R, Choe M, Seidel K, Huang W, Rawlings-Rhea SD, et al. Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial. Nature Medicine. 2025;31(3):861\u20138.","journal-title":"Nature Medicine"},{"issue":"1","key":"2164_CR79","doi-asserted-by":"publisher","first-page":"vdab027","DOI":"10.1093\/noajnl\/vdab027","volume":"3","author":"HE Olsen","year":"2021","unstructured":"Olsen HE, Lynn GM, Valdes PA, Cerecedo Lopez CD, Ishizuka AS, Arnaout O, et al. Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies. Neuro-Oncology Advances. 2021;3(1):vdab027.","journal-title":"Neuro-Oncology Advances"},{"key":"2164_CR80","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fonc.2018.00127","volume":"8","author":"D Benitez-Ribas","year":"2018","unstructured":"Benitez-Ribas D, Cabezon R, Florez-Grau G, Molero MC, Puerta P, Guillen A, et al. Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma. Frontiers in Oncology. 2018;8:127.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"2164_CR81","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-017-2643-1","volume":"136","author":"I Fried","year":"2018","unstructured":"Fried I, Lossos A, Ben Ami T, Dvir R, Toledano H, Ben Arush MW, et al. Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma. Journal of Neuro-Oncology. 2018;136(1):189\u201395.","journal-title":"Journal of Neuro-Oncology"},{"issue":"1","key":"2164_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10043-0","volume":"10","author":"N Martinez-Velez","year":"2019","unstructured":"Martinez-Velez N, Garcia-Moure M, Marigil M, Gonzalez-Huarriz M, Puigdelloses M, Gallego Perez-Larraya J, et al. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. Nature Communications. 2019;10(1):2235.","journal-title":"Nature Communications"},{"issue":"1","key":"2164_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11060-020-03504-w","volume":"148","author":"K Sheehan","year":"2020","unstructured":"Sheehan K, Sheehan D, Sulaiman M, Padilla F, Moore D, Sheehan J, et al. Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors. Journal of Neuro-Oncology. 2020;148(1):9\u201316.","journal-title":"Journal of Neuro-Oncology"},{"issue":"1","key":"2164_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46832-2","volume":"9","author":"SK Wu","year":"2019","unstructured":"Wu SK, Santos MA, Marcus SL, Hynynen K. MR-guided Focused Ultrasound Facilitates Sonodynamic Therapy with 5-Aminolevulinic Acid in a Rat Glioma Model. Scientific Reports. 2019;9(1):10465.","journal-title":"Scientific Reports"},{"issue":"826","key":"2164_CR85","doi-asserted-by":"publisher","first-page":"eads5813","DOI":"10.1126\/scitranslmed.ads5813","volume":"17","author":"N Sanai","year":"2025","unstructured":"Sanai N, Tovmasyan A, Tien AC, Chang YW, Margaryan T, Knight W, et al. An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma. Science translational medicine. 2025;17(826):eads5813.","journal-title":"Science translational medicine"},{"key":"2164_CR86","unstructured":"DIPG.org: DMG\/DIPG Trial Finder. In.; 2025."},{"key":"2164_CR87","unstructured":"Clinicaltrials.gov: Diffuse Midline Glioma (DMG) and Diffuse Intrinsic Pontine Glioma (DIPG) Clinical Trials. In., 2025 edn. National Library of Medicine (NIH)."},{"issue":"7","key":"2164_CR88","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2176\/nmc.ra.2017-0018","volume":"57","author":"R Hashizume","year":"2017","unstructured":"Hashizume R. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma. Neurol Med Chir (Tokyo). 2017;57(7):331\u201342.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"2164_CR89","doi-asserted-by":"publisher","first-page":"e0169485","DOI":"10.1371\/journal.pone.0169485","volume":"12","author":"T Hennika","year":"2017","unstructured":"Hennika T, Hu G, Olaciregui NG, Barton KL, Ehteda A, Chitranjan A, et al. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models. PLoS One. 2017;12(1):e0169485.","journal-title":"PLoS One"},{"issue":"5","key":"2164_CR90","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","volume":"138","author":"Z Wang","year":"2009","unstructured":"Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 2009;138(5):1019\u201331.","journal-title":"Cell"},{"issue":"12","key":"2164_CR91","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X, et al. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nature medicine. 2014;20(12):1394\u20136.","journal-title":"Nature medicine"},{"issue":"2","key":"2164_CR92","doi-asserted-by":"publisher","first-page":"108994","DOI":"10.1016\/j.celrep.2021.108994","volume":"35","author":"A Ehteda","year":"2021","unstructured":"Ehteda A, Simon S, Franshaw L, Giorgi FM, Liu J, Joshi S, et al. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell Rep. 2021;35(2):108994.","journal-title":"Cell Rep"},{"key":"2164_CR93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s42003-019-0420-8","volume":"2","author":"D Carvalho","year":"2019","unstructured":"Carvalho D, Taylor KR, Olaciregui NG, Molinari V, Clarke M, Mackay A, et al. ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma. Commun Biol. 2019;2:156.","journal-title":"Commun Biol"},{"issue":"3","key":"2164_CR94","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ccell.2020.02.002","volume":"37","author":"J Fortin","year":"2020","unstructured":"Fortin J, Tian R, Zarrabi I, Hill G, Williams E, Sanchez-Duffhues G, et al. Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas. Cancer Cell. 2020;37(3):308\u201323 e312.","journal-title":"Cancer Cell"},{"issue":"4","key":"2164_CR95","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad F, Weissmann S, Leblanc B, Pandey DP, Hojfeldt JW, Comet I, et al. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nature medicine. 2017;23(4):483\u201392.","journal-title":"Nature medicine"},{"key":"2164_CR96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13578-017-0184-0","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Dong W, Zhu J, Wang L, Wu X, Shan H. Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma. Cell Biosci. 2017;7:56.","journal-title":"Cell Biosci"},{"key":"2164_CR97","first-page":"100419","volume":"10","author":"F Shiridokht","year":"2025","unstructured":"Shiridokht F, Kehtari P, Eskandani M, Farajollahi A, Vandghanooni S. Advancing cancer radiotherapy: Harnessing radiosensitizers and nanotechnology for enhanced tumor control. Int J Pharm X. 2025;10:100419.","journal-title":"Int J Pharm X"},{"issue":"1","key":"2164_CR98","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40170-025-00411-4","volume":"13","author":"H Shen","year":"2025","unstructured":"Shen H, Huynh QS, Mudassar F, Chang C, Gloss B, Ing P, et al. Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells. Cancer Metab. 2025;13(1):43.","journal-title":"Cancer Metab"},{"issue":"1","key":"2164_CR99","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13046-020-01724-6","volume":"39","author":"F Mudassar","year":"2020","unstructured":"Mudassar F, Shen H, O'Neill G, Hau E. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J Exp Clin Cancer Res. 2020;39(1):208.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2164_CR100","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1570159X14666160223121002","volume":"15","author":"AL Bredlau","year":"2017","unstructured":"Bredlau AL, Dixit S, Chen C, Broome AM. Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma. Curr Neuropharmacol. 2017;15(1):104\u201315.","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"2164_CR101","doi-asserted-by":"publisher","first-page":"e1721","DOI":"10.1002\/wnan.1721","volume":"13","author":"DL Miyasato","year":"2021","unstructured":"Miyasato DL, Mohamed AW, Zavaleta C. A path toward the clinical translation of nano-based imaging contrast agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13(6):e1721.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"2164_CR102","first-page":"309","volume":"2","author":"M Upreti","year":"2013","unstructured":"Upreti M, Jyoti A, Sethi P. Tumor microenvironment and nanotherapeutics. Transl Cancer Res. 2013;2(4):309\u201319.","journal-title":"Transl Cancer Res"},{"issue":"9","key":"2164_CR103","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","volume":"2","author":"A Dasgupta","year":"2024","unstructured":"Dasgupta A, Sofias AM, Kiessling F, Lammers T. Nanoparticle Delivery to Tumours: From EPR and ATR Mechanisms to Clinical Impact. Nat Rev Bioeng. 2024;2(9):714\u20136.","journal-title":"Nat Rev Bioeng"},{"issue":"5","key":"2164_CR104","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41565-025-01877-5","volume":"20","author":"JLY Wu","year":"2025","unstructured":"Wu JLY, Ji Q, Blackadar C, Nguyen LNM, Lin ZP, Sepahi Z, et al. The pathways for nanoparticle transport across tumour endothelium. Nat Nanotechnol. 2025;20(5):672\u201382.","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"2164_CR105","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","volume":"11","author":"N Hoshyar","year":"2016","unstructured":"Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond). 2016;11(6):673\u201392.","journal-title":"Nanomedicine (Lond)"},{"key":"2164_CR106","doi-asserted-by":"publisher","first-page":"113731","DOI":"10.1016\/j.jconrel.2025.113731","volume":"382","author":"AA Gabizon","year":"2025","unstructured":"Gabizon AA. Cancer nanomedicine from a clinician-scientist perspective: Lessons and prospects. J Control Release. 2025;382:113731.","journal-title":"J Control Release"},{"key":"2164_CR107","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/pharmaceutics11050216","volume":"11","author":"R Edelman","year":"2019","unstructured":"Edelman R, Assaraf YG, Slavkin A, Dolev T, Shahar T, Livney YD. Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer. Pharmaceutics. 2019;11:216.","journal-title":"Pharmaceutics"},{"issue":"7","key":"2164_CR108","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0142-9612(01)00267-8","volume":"23","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23(7):1553\u201361.","journal-title":"Biomaterials"},{"issue":"9","key":"2164_CR109","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","volume":"7","author":"ME Davis","year":"2008","unstructured":"Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771\u201382.","journal-title":"Nat Rev Drug Discov"},{"issue":"320","key":"2164_CR110","doi-asserted-by":"publisher","first-page":"320ra324","DOI":"10.1126\/scitranslmed.aad0293","volume":"8","author":"MJ Whitley","year":"2016","unstructured":"Whitley MJ, Cardona DM, Lazarides AL, Spasojevic I, Ferrer JM, Cahill J, et al. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Science translational medicine. 2016;8(320):320ra324.","journal-title":"Science translational medicine"},{"key":"2164_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/srep21242","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Kang S, Khan A, Ruttner G, Leigh SY, Murray M, et al. Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy. Scientific reports. 2016;6:21242.","journal-title":"Scientific reports"},{"issue":"7","key":"2164_CR112","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1039\/C1CS15238F","volume":"41","author":"M Swierczewska","year":"2012","unstructured":"Swierczewska M, Liu G, Lee S, Chen X. High-sensitivity nanosensors for biomarker detection. Chem Soc Rev. 2012;41(7):2641\u201355.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"2164_CR113","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/SLA.0000000000002127","volume":"266","author":"KE Tipirneni","year":"2017","unstructured":"Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, et al. Oncologic Procedures Amenable to Fluorescence-guided Surgery. Ann Surg. 2017;266(1):36\u201347.","journal-title":"Ann Surg"},{"issue":"3","key":"2164_CR114","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1188\/17.ONF.358-365","volume":"44","author":"K Rodriguez","year":"2017","unstructured":"Rodriguez K, Wilkins GG, Newcomb P, Gwirtz PA, Skrine R. Risk Factors for Re-Excision Following Breast-Conserving Surgery. Oncol Nurs Forum. 2017;44(3):358\u201365.","journal-title":"Oncol Nurs Forum"},{"issue":"11","key":"2164_CR115","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/nnano.2015.251","volume":"10","author":"B Zhou","year":"2015","unstructured":"Zhou B, Shi B, Jin D, Liu X. Controlling upconversion nanocrystals for emerging applications. Nat Nanotechnol. 2015;10(11):924\u201336.","journal-title":"Nat Nanotechnol"},{"key":"2164_CR116","unstructured":"Cancer Nano-Therapies in the Clinic and Clinical Trials. In.: National Cancer Institute; 2023."},{"issue":"1","key":"2164_CR117","doi-asserted-by":"publisher","first-page":"e1927","DOI":"10.1002\/wnan.1927","volume":"16","author":"CS Morales","year":"2024","unstructured":"Morales CS, Grodzinski P. Current landscape of treating different cancers using nanomedicines: Trends and perspectives. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16(1):e1927.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"2164_CR118","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s11671-023-03943-0","volume":"18","author":"G Unnikrishnan","year":"2023","unstructured":"Unnikrishnan G, Joy A, Megha M, Kolanthai E, Senthilkumar M. Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review. Discov Nano. 2023;18(1):157.","journal-title":"Discov Nano"},{"issue":"39","key":"2164_CR119","doi-asserted-by":"publisher","first-page":"43408","DOI":"10.1021\/acsami.0c12042","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Fu X, Jia J, Wikerholmen T, Xi K, Kong Y, et al. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles. ACS Appl Mater Interfaces. 2020;12(39):43408\u201321.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2164_CR120","doi-asserted-by":"publisher","first-page":"2007166","DOI":"10.1002\/adfm.202007166","volume":"31","author":"K Wang","year":"2021","unstructured":"Wang K, Kievit FM, Chiarelli PA, Stephen ZR, Lin G, Silber JR, et al. siRNA nanoparticle suppresses drug-resistant gene and prolongs survival in an orthotopic glioblastoma xenograft mouse model. Adv Funct Mater. 2021;31:2007166.","journal-title":"Adv Funct Mater"},{"issue":"18","key":"2164_CR121","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1158\/0008-5472.CAN-18-2998","volume":"79","author":"ZR Stephen","year":"2019","unstructured":"Stephen ZR, Chiarelli PA, Revia RA, Wang K, Kievit F, Dayringer C, et al. Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model. Cancer Research. 2019;79(18):4776\u201386.","journal-title":"Cancer Research"},{"key":"2164_CR122","doi-asserted-by":"publisher","first-page":"1802227","DOI":"10.1002\/adfm.201802227","volume":"28","author":"S Ruan","year":"2018","unstructured":"Ruan S, Qin L, Xiao W, Hu C, Zhou Y, Wang R, et al. Acid-Responsive Transferrin Dissociation and GLUT Mediated Exocytosis for Increased Blood\u2013Brain Barrier Transcytosis and Programmed Glioma Targeting Delivery. Advanced Functional Materials. 2018;28:1802227.","journal-title":"Advanced Functional Materials"},{"issue":"3","key":"2164_CR123","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10103-007-0470-x","volume":"23","author":"X Huang","year":"2008","unstructured":"Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008;23(3):217\u201328.","journal-title":"Lasers Med Sci"},{"issue":"4","key":"2164_CR124","doi-asserted-by":"publisher","first-page":"e62425","DOI":"10.1371\/journal.pone.0062425","volume":"8","author":"DY Joh","year":"2013","unstructured":"Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One. 2013;8(4):e62425.","journal-title":"PLoS One"},{"key":"2164_CR125","doi-asserted-by":"publisher","unstructured":"Biswal P, Vijay GV, Krouse G, Mai PMQ, Lakshmisha BM, Shahbaz SK, et al: Tumor radiosensitization with gold nanoparticles: evolving strategies to improve tumoral gold uptake and catalyze future clinical translation. ACS Nano Med 2026. https:\/\/doi.org\/10.1021\/acsnanomed.5c00110.","DOI":"10.1021\/acsnanomed.5c00110"},{"key":"2164_CR126","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.biomaterials.2017.04.045","volume":"135","author":"JL Campbell","year":"2017","unstructured":"Campbell JL, SoRelle ED, Ilovich O, Liba O, James ML, Qiu Z, et al. Multimodal assessment of SERS nanoparticle biodistribution post ingestion reveals new potential for clinical translation of Raman imaging. Biomaterials. 2017;135:42\u201352.","journal-title":"Biomaterials"},{"key":"2164_CR127","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2147\/IJN.S246764","volume":"15","author":"IX Yin","year":"2020","unstructured":"Yin IX, Zhang J, Zhao IS, Mei ML, Li Q, Chu CH. The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry. Int J Nanomedicine. 2020;15:2555\u201362.","journal-title":"Int J Nanomedicine"},{"key":"2164_CR128","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/diagnostics12010173","volume":"12","author":"C Guido","year":"2022","unstructured":"Guido C, Baldari C, Maiorano G, Mastronuzzi A, Carai A, Quintarelli C, et al. Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers. Diagnostics (Basel). 2022;12:173.","journal-title":"Diagnostics (Basel)"},{"issue":"23","key":"2164_CR129","doi-asserted-by":"publisher","first-page":"11829","DOI":"10.1039\/c3nr01351k","volume":"5","author":"P Liu","year":"2013","unstructured":"Liu P, Huang Z, Chen Z, Xu R, Wu H, Zang F, et al. Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale. 2013;5(23):11829\u201336.","journal-title":"Nanoscale"},{"key":"2164_CR130","doi-asserted-by":"publisher","first-page":"S922","DOI":"10.1080\/21691401.2018.1518912","volume":"46","author":"Z Liu","year":"2018","unstructured":"Liu Z, Tan H, Zhang X, Chen F, Zhou Z, Hu X, et al. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells. Artif Cells Nanomed Biotechnol. 2018;46:S922\u2013S930. sup3","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"6","key":"2164_CR131","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1166\/jnn.2013.7156","volume":"13","author":"R Wang","year":"2013","unstructured":"Wang R, Chen C, Yang W, Shi S, Wang C, Chen J. Enhancement effect of cytotoxicity response of silver nanoparticles combined with thermotherapy on C6 rat glioma cells. J Nanosci Nanotechnol. 2013;13(6):3851\u20134.","journal-title":"J Nanosci Nanotechnol"},{"issue":"11","key":"2164_CR132","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1166\/jnn.2012.6626","volume":"12","author":"H Jiang","year":"2012","unstructured":"Jiang H, Wang C, Guo Z, Wang Z, Liu L. Silver nanocrystals mediated combination therapy of radiation with magnetic hyperthermia on glioma cells. J Nanosci Nanotechnol. 2012;12(11):8276\u201381.","journal-title":"J Nanosci Nanotechnol"},{"issue":"4","key":"2164_CR133","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00432-024-05641-5","volume":"150","author":"S Abdolmaleki","year":"2024","unstructured":"Abdolmaleki S, Aliabadi A, Khaksar S. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review. J Cancer Res Clin Oncol. 2024;150(4):213.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"48","key":"2164_CR134","doi-asserted-by":"publisher","first-page":"34045","DOI":"10.1039\/D3RA06434D","volume":"13","author":"R Cazzoli","year":"2023","unstructured":"Cazzoli R, Zamborlin A, Ermini ML, Salerno A, Curcio M, Nicoletta FP, et al. Evolving approaches in glioma treatment: harnessing the potential of copper metabolism modulation. RSC Adv. 2023;13(48):34045\u201356.","journal-title":"RSC Adv"},{"key":"2164_CR135","doi-asserted-by":"publisher","first-page":"e00828","DOI":"10.1016\/j.btre.2024.e00828","volume":"41","author":"YT Gebreslassie","year":"2024","unstructured":"Gebreslassie YT, Gebremeskel FG. Green and cost-effective biofabrication of copper oxide nanoparticles: Exploring antimicrobial and anticancer applications. Biotechnol Rep (Amst). 2024;41:e00828.","journal-title":"Biotechnol Rep (Amst)"},{"key":"2164_CR136","doi-asserted-by":"publisher","first-page":"122805","DOI":"10.1016\/j.biomaterials.2024.122805","volume":"313","author":"SR Li","year":"2025","unstructured":"Li SR, Tao SY, Li Q, Hu CY, Sun ZJ. Harnessing nanomaterials for copper-induced cell death. Biomaterials. 2025;313:122805.","journal-title":"Biomaterials"},{"key":"2164_CR137","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/ma12101588","volume":"12","author":"A Zottel","year":"2019","unstructured":"Zottel A, Videti\u010d Paska A, Jov\u010devska I. Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy. Materials (Basel). 2019;12:1588.","journal-title":"Materials (Basel)"},{"issue":"1","key":"2164_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01477-8","volume":"20","author":"N Joudeh","year":"2022","unstructured":"Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnology. 2022;20(1):262.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"2164_CR139","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4155\/tde-2017-0071","volume":"8","author":"T Nakamura","year":"2017","unstructured":"Nakamura T, Harashima H. Integration of nano drug-delivery system with cancer immunotherapy. Ther Deliv. 2017;8(11):987\u20131000.","journal-title":"Ther Deliv"},{"issue":"4","key":"2164_CR140","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/10611860600650086","volume":"14","author":"MW Smith","year":"2006","unstructured":"Smith MW, Gumbleton M. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target. 2006;14(4):191\u2013214.","journal-title":"J Drug Target"},{"issue":"5","key":"2164_CR141","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.7150\/thno.122658","volume":"16","author":"Q Zhan","year":"2026","unstructured":"Zhan Q, Yi K, Yang S, Hong B, Su D, Zhao J, et al. LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields\/TMZ via TALECT regimen in glioblastoma. Theranostics. 2026;16(5):2249\u201368.","journal-title":"Theranostics"},{"issue":"1","key":"2164_CR142","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.expneurol.2003.12.013","volume":"187","author":"MT da Cruz","year":"2004","unstructured":"da Cruz MT, Simoes S, de Lima MC. Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons. Exp Neurol. 2004;187(1):65\u201375.","journal-title":"Exp Neurol"},{"issue":"1","key":"2164_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18100-8","volume":"8","author":"JB Bell","year":"2018","unstructured":"Bell JB, Rink JS, Eckerdt F, Clymer J, Goldman S, Thaxton CS, et al. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma. Scientific reports. 2018;8(1):1211.","journal-title":"Scientific reports"},{"key":"2164_CR144","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/polym14142963","volume":"14","author":"CA Caraway","year":"2022","unstructured":"Caraway CA, Gaitsch H, Wicks EE, Kalluri A, Kunadi N, Tyler BM. Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches. Polymers (Basel). 2022;14:2963.","journal-title":"Polymers (Basel)"},{"issue":"39","key":"2164_CR145","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1039\/C9TB01131E","volume":"7","author":"S Agarwal","year":"2019","unstructured":"Agarwal S, Mohamed MS, Mizuki T, Maekawa T, Sakthi Kumar D. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy. J Mater Chem B. 2019;7(39):5896\u2013919.","journal-title":"J Mater Chem B"},{"issue":"11","key":"2164_CR146","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/jbm.a.36477","volume":"106","author":"TM Brenza","year":"2018","unstructured":"Brenza TM, Schlichtmann BW, Bhargavan B, Vela Ramirez JE, Nelson RD, Panthani MG, et al. Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery. J Biomed Mater Res A. 2018;106(11):2881\u201390.","journal-title":"J Biomed Mater Res A"},{"key":"2164_CR147","doi-asserted-by":"publisher","first-page":"102115","DOI":"10.1016\/j.nano.2019.102115","volume":"23","author":"J Choi","year":"2020","unstructured":"Choi J, Rui Y, Kim J, Gorelick N, Wilson DR, Kozielski K, et al. Nonviral polymeric nanoparticles for gene therapy in pediatric CNS malignancies. Nanomedicine : Nanotechnology, Biology, and Medicine. 2020;23:102115.","journal-title":"Nanomedicine : Nanotechnology, Biology, and Medicine"},{"issue":"1","key":"2164_CR148","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1021\/mp300391v","volume":"10","author":"L Albertazzi","year":"2013","unstructured":"Albertazzi L, Gherardini L, Brondi M, Sulis Sato S, Bifone A, Pizzorusso T, et al. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Mol Pharm. 2013;10(1):249\u201360.","journal-title":"Mol Pharm"},{"issue":"4","key":"2164_CR149","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ntno.38954","volume":"3","author":"C Liu","year":"2019","unstructured":"Liu C, Zhao Z, Gao H, Rostami I, You Q, Jia X, et al. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics. 2019;3(4):311\u201330.","journal-title":"Nanotheranostics"},{"key":"2164_CR150","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.canlet.2020.11.028","volume":"499","author":"P Infante","year":"2021","unstructured":"Infante P, Malfanti A, Quaglio D, Balducci S, De Martin S, Bufalieri F, et al. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma. Cancer Lett. 2021;499:220\u201331.","journal-title":"Cancer Lett"},{"key":"2164_CR151","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/pharmaceutics18020177","volume":"18","author":"RG Bryaskova","year":"2026","unstructured":"Bryaskova RG, Staykov KG, Ganchev DS. Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems. Pharmaceutics. 2026;18:177.","journal-title":"Pharmaceutics"},{"key":"2164_CR152","doi-asserted-by":"publisher","first-page":"113616","DOI":"10.1016\/j.jconrel.2025.113616","volume":"381","author":"J German-Cort\u00e9s","year":"2025","unstructured":"German-Cort\u00e9s J, Herrero R, Torroglosa N, Pumarola A, Fischer-Albiol N, Campos-Moreno S, et al. Preclinical evaluation of several polymeric micelles identifies Soluplus\u00ae-docetaxel as the most effective candidate in multiple glioblastoma models. J Control Release. 2025;381:113616.","journal-title":"J Control Release"},{"issue":"1","key":"2164_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44963-3","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Xu X, Du J, Chen X, Xue Y, Zhang J, et al. Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy. Nature Communications. 2024;15(1):1118.","journal-title":"Nature Communications"},{"key":"2164_CR154","doi-asserted-by":"publisher","first-page":"1265347","DOI":"10.3389\/fonc.2023.1265347","volume":"13","author":"D Elsori","year":"2023","unstructured":"Elsori D, Rashid G, Khan NA, Sachdeva P, Jindal R, Kayenat F, et al. Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer\u2019s disease and brain tumors. Frontiers in Oncology. 2023;13:1265347.","journal-title":"Frontiers in Oncology"},{"issue":"13","key":"2164_CR155","doi-asserted-by":"publisher","first-page":"eade5321","DOI":"10.1126\/sciadv.ade5321","volume":"9","author":"X Wang","year":"2023","unstructured":"Wang X, Gong Z, Wang T, Law J, Chen X, Wanggou S, et al. Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes. Sci Adv. 2023;9(13):eade5321.","journal-title":"Sci Adv"},{"key":"2164_CR156","doi-asserted-by":"publisher","first-page":"9562","DOI":"10.3390\/ijms24119562","volume":"24","author":"FA Vallejo","year":"2023","unstructured":"Vallejo FA, Sigdel G, Veliz EA, Leblanc RM, Vanni S, Graham RM. Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions. Int J Mol Sci. 2023;24:9562.","journal-title":"Int J Mol Sci"},{"issue":"37","key":"2164_CR157","doi-asserted-by":"publisher","first-page":"16662","DOI":"10.1039\/C6NR05055G","volume":"8","author":"S Li","year":"2016","unstructured":"Li S, Amat D, Peng Z, Vanni S, Raskin S, De Angulo G, et al. Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells. Nanoscale. 2016;8(37):16662\u20139.","journal-title":"Nanoscale"},{"issue":"14","key":"2164_CR158","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1039\/D0NR01647K","volume":"12","author":"PY Liyanage","year":"2020","unstructured":"Liyanage PY, Zhou Y, Al-Youbi AO, Bashammakh AS, El-Shahawi MS, Vanni S, et al. Pediatric glioblastoma target-specific efficient delivery of gemcitabine across the blood-brain barrier via carbon nitride dots. Nanoscale. 2020;12(14):7927\u201338.","journal-title":"Nanoscale"},{"issue":"2","key":"2164_CR159","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4155\/tde.15.93","volume":"7","author":"SC Patel","year":"2016","unstructured":"Patel SC, Lee S, Lalwani G, Suhrland C, Chowdhury SM, Sitharaman B. Graphene-based platforms for cancer therapeutics. Ther Deliv. 2016;7(2):101\u201316.","journal-title":"Ther Deliv"},{"issue":"3","key":"2164_CR160","doi-asserted-by":"publisher","first-page":"e2201968","DOI":"10.1002\/adhm.202201968","volume":"12","author":"PS Sharp","year":"2023","unstructured":"Sharp PS, Stylianou M, Arellano LM, Neves JC, Gravagnuolo AM, Dodd A, et al. Graphene Oxide Nanoscale Platform Enhances the Anti-Cancer Properties of Bortezomib in Glioblastoma Models. Adv Healthc Mater. 2023;12(3):e2201968.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"2164_CR161","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acsbiomaterials.3c00104","volume":"9","author":"\u015e Ta\u015fdemir","year":"2023","unstructured":"Ta\u015fdemir \u015e, Mor\u00e7imen ZG, Do\u011fan AA, G\u00f6rg\u00fcn C, \u015eendemir A. Surface Area of Graphene Governs Its Neurotoxicity. ACS Biomater Sci Eng. 2023;9(6):3297\u2013305.","journal-title":"ACS Biomater Sci Eng"},{"key":"2164_CR162","doi-asserted-by":"publisher","first-page":"9771","DOI":"10.2147\/IJN.S476601","volume":"19","author":"W Hou","year":"2024","unstructured":"Hou W, Shen L, Zhu Y, Wang X, Du T, Yang F, et al. Fullerene Derivatives for Tumor Treatment: Mechanisms and Application. Int J Nanomedicine. 2024;19:9771\u201397.","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"2164_CR163","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.1039\/D1RA08499B","volume":"12","author":"M Serda","year":"2022","unstructured":"Serda M, Gawecki R, Dulski M, Sajewicz M, Talik E, Szubka M, et al. Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles. RSC Adv. 2022;12(11):6377\u201388.","journal-title":"RSC Adv"},{"issue":"8","key":"2164_CR164","doi-asserted-by":"publisher","first-page":"e2413389","DOI":"10.1002\/advs.202413389","volume":"12","author":"B Zhang","year":"2025","unstructured":"Zhang B, Yang L, Jin Y, Lu Y, Li J, Tang G, et al. Ferritin-Based Supramolecular Assembly Drug Delivery System for Aminated Fullerene Derivatives to Enhance Tumor-Targeted Therapy. Adv Sci (Weinh). 2025;12(8):e2413389.","journal-title":"Adv Sci (Weinh)"},{"issue":"13","key":"2164_CR165","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1021\/acsami.7b01077","volume":"9","author":"FY Hsieh","year":"2017","unstructured":"Hsieh FY, Zhilenkov AV, Voronov II, Khakina EA, Mischenko DV, Troshin PA, et al. Water-Soluble Fullerene Derivatives as Brain Medicine: Surface Chemistry Determines If They Are Neuroprotective and Antitumor. ACS Appl Mater Interfaces. 2017;9(13):11482\u201392.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2164_CR166","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE. Diffuse intrinsic pontine glioma: poised for progress. Frontiers in Oncology. 2012;2:205.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"2164_CR167","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/157488608783333989","volume":"3","author":"MA Perazella","year":"2008","unstructured":"Perazella MA. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf. 2008;3(1):67\u201375.","journal-title":"Curr Drug Saf"},{"issue":"4","key":"2164_CR168","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2214\/AJR.22.28453","volume":"220","author":"LC Adams","year":"2023","unstructured":"Adams LC, Jayapal P, Ramasamy SK, Morakote W, Yeom K, Baratto L, et al. Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art. AJR Am J Roentgenol. 2023;220(4):590\u2013603.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2164_CR169","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117\u201334.","journal-title":"J Control Release"},{"key":"2164_CR170","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jcis.2014.07.032","volume":"433","author":"I Tsiapa","year":"2014","unstructured":"Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, et al. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of alphanubeta3-mediated tumor expression and feasibility for hyperthermia treatment. J Colloid Interface Sci. 2014;433:163\u201375.","journal-title":"J Colloid Interface Sci"},{"issue":"22","key":"2164_CR171","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1158\/1078-0432.CCR-06-0946","volume":"12","author":"GR Reddy","year":"2006","unstructured":"Reddy GR, Bhojani MS, McConville P, Moody J, Moffat BA, Hall DE, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clinical Cancer Research. 2006;12(22):6677\u201386.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"2164_CR172","first-page":"364","volume":"19","author":"R Yang","year":"2017","unstructured":"Yang R, Sarkar S, Korchinski DJ, Wu Y, Yong VW, Dunn JF. MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor. Neuro-Oncology. 2017;19(3):364\u201371.","journal-title":"Neuro-Oncology"},{"issue":"24","key":"2164_CR173","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1002\/smll.201400654","volume":"10","author":"Y Cheng","year":"2014","unstructured":"Cheng Y, Dai Q, Morshed RA, Fan X, Wegscheid ML, Wainwright DA, et al. Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging. Small. 2014;10(24):5137\u201350.","journal-title":"Small"},{"issue":"23","key":"2164_CR174","doi-asserted-by":"publisher","first-page":"e1800740","DOI":"10.1002\/smll.201800740","volume":"14","author":"V Neuschmelting","year":"2018","unstructured":"Neuschmelting V, Harmsen S, Beziere N, Lockau H, Hsu HT, Huang R, et al. Dual-Modality Surface-Enhanced Resonance Raman Scattering and Multispectral Optoacoustic Tomography Nanoparticle Approach for Brain Tumor Delineation. Small. 2018;14(23):e1800740.","journal-title":"Small"},{"issue":"5","key":"2164_CR175","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nm.2721","volume":"18","author":"MF Kircher","year":"2012","unstructured":"Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, et al. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nature medicine. 2012;18(5):829\u201334.","journal-title":"Nature medicine"},{"issue":"10","key":"2164_CR176","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.2967\/jnumed.114.141861","volume":"55","author":"C Perez-Medina","year":"2014","unstructured":"Perez-Medina C, Abdel-Atti D, Zhang Y, Longo VA, Irwin CP, Binderup T, et al. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. J Nucl Med. 2014;55(10):1706\u201311.","journal-title":"J Nucl Med"},{"issue":"9","key":"2164_CR177","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.7150\/thno.21670","volume":"8","author":"H Lee","year":"2018","unstructured":"Lee H, Gaddy D, Ventura M, Bernards N, de Souza R, Kirpotin D, et al. Companion Diagnostic (64)Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines. Theranostics. 2018;8(9):2300\u201312.","journal-title":"Theranostics"},{"issue":"44","key":"2164_CR178","doi-asserted-by":"publisher","first-page":"445104","DOI":"10.1088\/0957-4484\/25\/44\/445104","volume":"25","author":"A Ray","year":"2014","unstructured":"Ray A, Mukundan A, Xie Z, Karamchand L, Wang X, Kopelman R. Highly stable polymer coated nano-clustered silver plates: a multimodal optical contrast agent for biomedical imaging. Nanotechnology. 2014;25(44):445104.","journal-title":"Nanotechnology"},{"key":"2164_CR179","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Frohlich","year":"2012","unstructured":"Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012;7:5577\u201391.","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"2164_CR180","doi-asserted-by":"publisher","first-page":"96002","DOI":"10.1117\/1.JBO.19.9.096002","volume":"19","author":"K Kanazaki","year":"2014","unstructured":"Kanazaki K, Sano K, Makino A, Takahashi A, Deguchi J, Ohashi M, et al. Development of human serum albumin conjugated with near-infrared dye for photoacoustic tumor imaging. J Biomed Opt. 2014;19(9):96002.","journal-title":"J Biomed Opt"},{"issue":"3","key":"2164_CR181","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1039\/C3CS60273G","volume":"43","author":"V Biju","year":"2014","unstructured":"Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev. 2014;43(3):744\u201364.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"2164_CR182","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1039\/B700091J","volume":"133","author":"J Yang","year":"2008","unstructured":"Yang J, Gunn J, Dave SR, Zhang M, Wang YA, Gao X. Ultrasensitive detection and molecular imaging with magnetic nanoparticles. Analyst. 2008;133(2):154\u201360.","journal-title":"Analyst"},{"issue":"1","key":"2164_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76500-z","volume":"14","author":"N Zhylkybayeva","year":"2024","unstructured":"Zhylkybayeva N, Paliienko K, Topchylo A, Zaderko A, G\u00e9lo\u00ebn A, Borisova T, et al. Size dependent properties of Gd(3+)-free versus Gd(3+)-doped carbon dots for bioimaging application. Scientific reports. 2024;14(1):27812.","journal-title":"Scientific reports"},{"issue":"27","key":"2164_CR184","doi-asserted-by":"publisher","first-page":"12973","DOI":"10.1039\/C9NR03988K","volume":"11","author":"X He","year":"2019","unstructured":"He X, Luo Q, Zhang J, Chen P, Wang HJ, Luo K, et al. Gadolinium-doped carbon dots as nano-theranostic agents for MR\/FL diagnosis and gene delivery. Nanoscale. 2019;11(27):12973\u201382.","journal-title":"Nanoscale"},{"issue":"41","key":"2164_CR185","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1002\/adfm.201401451","volume":"24","author":"H Gong","year":"2014","unstructured":"Gong H, Dong Z, Liu Y, Yin S, Cheng L, Xi W, et al. Engineering of Multifunctional Nano-Micelles for Combined Photothermal and Photodynamic Therapy Under the Guidance of Multimodal Imaging. Advanced Functional Materials. 2014;24(41):6492\u2013502.","journal-title":"Advanced Functional Materials"},{"key":"2164_CR186","first-page":"393","volume":"7","author":"NH Gamage","year":"2016","unstructured":"Gamage NH, Jing L, Worsham MJ, Ali MM. Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle. J Nanomed Nanotechnol. 2016;7:393.","journal-title":"J Nanomed Nanotechnol"},{"key":"2164_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-51","volume":"7","author":"H Sarin","year":"2009","unstructured":"Sarin H, Kanevsky AS, Wu H, Sousa AA, Wilson CM, Aronova MA, et al. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J Transl Med. 2009;7:51.","journal-title":"J Transl Med"},{"issue":"3","key":"2164_CR188","doi-asserted-by":"publisher","first-page":"e200052","DOI":"10.1148\/rycan.2021200052","volume":"3","author":"CH Liu","year":"2021","unstructured":"Liu CH, Grodzinski P. Nanotechnology for Cancer Imaging: Advances, Challenges, and Clinical Opportunities. Radiol Imaging Cancer. 2021;3(3):e200052.","journal-title":"Radiol Imaging Cancer"},{"issue":"30","key":"2164_CR189","doi-asserted-by":"publisher","first-page":"35266","DOI":"10.1021\/acsami.1c04164","volume":"13","author":"V Heravi Shargh","year":"2021","unstructured":"Heravi Shargh V, Luckett J, Bouzinab K, Paisey S, Turyanska L, Singleton WGB, et al. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue. ACS Appl Mater Interfaces. 2021;13(30):35266\u201380.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2164_CR190","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/cancers13061278","volume":"13","author":"C Ung","year":"2021","unstructured":"Ung C, Tsoli M, Liu J, Cassano D, Pocovi-Martinez S, Upton DH, et al. Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine Glioma. Cancers (Basel). 2021;13:1278.","journal-title":"Cancers (Basel)"},{"key":"2164_CR191","doi-asserted-by":"publisher","first-page":"i103","DOI":"10.1093\/neuonc\/noy059.340","volume":"20","author":"A Lenzen","year":"2018","unstructured":"Lenzen A, Cole L, Lauing KL, Zhai L, Ladomersky E, Lulla RR, et al. IMMU-24. IMMUNOTHERAPEUTIC NANOTECHNOLOGY TARGETING IDO1 FOR PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA. Neuro Oncology. 2018;20:i103.","journal-title":"Neuro Oncology"},{"issue":"3","key":"2164_CR192","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/neuonc\/nor190","volume":"14","author":"KE Warren","year":"2012","unstructured":"Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS. Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro-Oncology. 2012;14(3):326\u201332.","journal-title":"Neuro-Oncology"},{"issue":"10","key":"2164_CR193","doi-asserted-by":"publisher","first-page":"e77639","DOI":"10.1371\/journal.pone.0077639","volume":"8","author":"KL Barton","year":"2013","unstructured":"Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M, et al. PD-0332991, a CDK4\/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One. 2013;8(10):e77639.","journal-title":"PLoS One"},{"issue":"3","key":"2164_CR194","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-023-02609-6","volume":"146","author":"EA Williams","year":"2023","unstructured":"Williams EA, Brastianos PK, Wakimoto H, Zolal A, Filbin MG, Cahill DP, et al. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta neuropathologica. 2023;146(3):515\u201325.","journal-title":"Acta neuropathologica"},{"issue":"4","key":"2164_CR195","doi-asserted-by":"publisher","first-page":"e13153","DOI":"10.1111\/bpa.13153","volume":"33","author":"RC Chai","year":"2023","unstructured":"Chai RC, Yan H, An SY, Pang B, Chen HY, Mu QH, et al. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma. Brain Pathol. 2023;33(4):e13153.","journal-title":"Brain Pathol"},{"issue":"8","key":"2164_CR196","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","volume":"28","author":"M Zarghooni","year":"2010","unstructured":"Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, et al. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. Journal of Clinical Oncology. 2010;28(8):1337\u201344.","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"2164_CR197","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/neuonc\/not220","volume":"16","author":"S Mueller","year":"2014","unstructured":"Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow AK, Phillips J, et al. Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro-Oncology. 2014;16(3):352\u201360.","journal-title":"Neuro-Oncology"},{"issue":"39","key":"2164_CR198","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1038\/s41388-025-03533-7","volume":"44","author":"M Upreti","year":"2025","unstructured":"Upreti M, Petrosyan A, Thornton ME, Hovsepyan A, Fernandez GE, Koos DS, et al. Multicellular tumor-stromal interactions recapitulate aspects of therapeutic response and human oncogenic signaling in a 3D disease model for H3K27M-altered DIPG. Oncogene. 2025;44(39):3694\u2013712.","journal-title":"Oncogene"},{"issue":"6","key":"2164_CR199","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1074\/jbc.M205662200","volume":"278","author":"J Deshane","year":"2003","unstructured":"Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem. 2003;278(6):4135\u201344.","journal-title":"J Biol Chem"},{"issue":"1","key":"2164_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0462-6","volume":"17","author":"L Zhao","year":"2019","unstructured":"Zhao L, Li Y, Zhu J, Sun N, Song N, Xing Y, et al. Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT\/CT imaging and radionuclide therapy. J Nanobiotechnology. 2019;17(1):30.","journal-title":"J Nanobiotechnology"},{"issue":"9","key":"2164_CR201","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.biomaterials.2010.11.079","volume":"32","author":"R Huang","year":"2011","unstructured":"Huang R, Ke W, Han L, Li J, Liu S, Jiang C. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. Biomaterials. 2011;32(9):2399\u2013406.","journal-title":"Biomaterials"},{"key":"2164_CR202","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.3390\/cancers15133388","volume":"15","author":"T Boltman","year":"2023","unstructured":"Boltman T, Meyer M, Ekpo O. Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles. Cancers (Basel). 2023;15:3388.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2164_CR203","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1038\/mtna.2013.30","volume":"2","author":"PM Costa","year":"2013","unstructured":"Costa PM, Cardoso AL, Mendonca LS, Serani A, Custodia C, Conceicao M, et al. Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment. Mol Ther Nucleic Acids. 2013;2(6):e100.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2164_CR204","doi-asserted-by":"publisher","first-page":"1192448","DOI":"10.3389\/fonc.2023.1192448","volume":"13","author":"K Pandey","year":"2023","unstructured":"Pandey K, Wang SS, Mifsud NA, Faridi P, Davenport AJ, Webb AI, et al. A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. Frontiers in Oncology. 2023;13:1192448.","journal-title":"Frontiers in Oncology"},{"key":"2164_CR205","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/pharmaceutics13111897","volume":"13","author":"C Riccardi","year":"2021","unstructured":"Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone MAB. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics. 2021;13:1897.","journal-title":"Pharmaceutics"},{"issue":"3","key":"2164_CR206","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","volume":"86","author":"R Singh","year":"2009","unstructured":"Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215\u201323.","journal-title":"Exp Mol Pathol"},{"key":"2164_CR207","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351. Pt A","journal-title":"Adv Drug Deliv Rev"},{"issue":"13","key":"2164_CR208","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1039\/C9NR00207C","volume":"11","author":"Y Xia","year":"2019","unstructured":"Xia Y, Xu C, Zhang X, Ning P, Wang Z, Tian J, et al. Liposome-based probes for molecular imaging: from basic research to the bedside. Nanoscale. 2019;11(13):5822\u201338.","journal-title":"Nanoscale"},{"issue":"16","key":"2164_CR209","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.1103573108","volume":"108","author":"CH Choi","year":"2011","unstructured":"Choi CH, Zuckerman JE, Webster P, Davis ME. Targeting kidney mesangium by nanoparticles of defined size. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(16):6656\u201361.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"2164_CR210","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/nl900031y","volume":"9","author":"SD Perrault","year":"2009","unstructured":"Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909\u201315.","journal-title":"Nano Lett"},{"issue":"46","key":"2164_CR211","doi-asserted-by":"publisher","first-page":"8649","DOI":"10.1002\/anie.201003142","volume":"49","author":"Z Popovic","year":"2010","unstructured":"Popovic Z, Liu W, Chauhan VP, Lee J, Wong C, Greytak AB, et al. A nanoparticle size series for in vivo fluorescence imaging. Angew Chem Int Ed Engl. 2010;49(46):8649\u201352.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"2164_CR212","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505\u201315.","journal-title":"Mol Pharm"},{"key":"2164_CR213","doi-asserted-by":"publisher","DOI":"10.1038\/srep15236","volume":"5","author":"A Jyoti","year":"2015","unstructured":"Jyoti A, Fugit KD, Sethi P, McGarry RC, Anderson BD, Upreti M. An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids. Scientific reports. 2015;5:15236.","journal-title":"Scientific reports"},{"key":"2164_CR214","doi-asserted-by":"publisher","first-page":"216990","DOI":"10.1016\/j.canlet.2024.216990","volume":"594","author":"A Kirti","year":"2024","unstructured":"Kirti A, Simnani FZ, Jena S, Lenka SS, Kalalpitiya C, Naser SS, et al. Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence. Cancer Lett. 2024;594:216990.","journal-title":"Cancer Lett"},{"issue":"37","key":"2164_CR215","doi-asserted-by":"publisher","first-page":"62742","DOI":"10.18632\/oncotarget.18409","volume":"8","author":"HHW Chen","year":"2017","unstructured":"Chen HHW, Kuo MT. Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget. 2017;8(37):62742\u201358.","journal-title":"Oncotarget"},{"key":"2164_CR216","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/cancers15061892","volume":"15","author":"M Haque","year":"2023","unstructured":"Haque M, Shakil MS, Mahmud KM. The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment. Cancers (Basel). 2023;15:1892.","journal-title":"Cancers (Basel)"},{"key":"2164_CR217","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/pharmaceutics13081295","volume":"13","author":"KM Mahmud","year":"2021","unstructured":"Mahmud KM, Niloy MS, Shakil MS, Islam MA. Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment. Pharmaceutics. 2021;13:1295.","journal-title":"Pharmaceutics"},{"issue":"8","key":"2164_CR218","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.nano.2016.06.010","volume":"12","author":"H Yao","year":"2016","unstructured":"Yao H, Qiu H, Shao Z, Wang G, Wang J, Yao Y, et al. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy. Nanomedicine: Nanotechnology, Biology, and Medicine. 2016;12(8):2261\u201371.","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"2","key":"2164_CR219","doi-asserted-by":"publisher","first-page":"02TR01","DOI":"10.1088\/1361-6560\/aa99ce","volume":"63","author":"Z Kuncic","year":"2018","unstructured":"Kuncic Z, Lacombe S. Nanoparticle radio-enhancement: principles, progress and application to cancer treatment. Phys Med Biol. 2018;63(2):02TR01.","journal-title":"Phys Med Biol"},{"key":"2164_CR220","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.nano.2018.12.007","volume":"16","author":"A Kefayat","year":"2019","unstructured":"Kefayat A, Ghahremani F, Motaghi H, Amouheidari A. Ultra-small but ultra-effective: Folic acid-targeted gold nanoclusters for enhancement of intracranial glioma tumors\u2019 radiation therapy efficacy. Nanomedicine : Nanotechnology, Biology, and Medicine. 2019;16:173\u201384.","journal-title":"Nanomedicine : Nanotechnology, Biology, and Medicine"},{"key":"2164_CR221","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/ijms21020429","volume":"21","author":"F Kazmi","year":"2020","unstructured":"Kazmi F, Vallis KA, Vellayappan BA, Bandla A, Yukun D, Carlisle R. Megavoltage Radiosensitization of Gold Nanoparticles on a Glioblastoma Cancer Cell Line Using a Clinical Platform. Int J Mol Sci. 2020;21:429.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2164_CR222","doi-asserted-by":"publisher","first-page":"055101","DOI":"10.1088\/1361-6528\/aaedd5","volume":"30","author":"T Kunoh","year":"2019","unstructured":"Kunoh T, Shimura T, Kasai T, Matsumoto S, Mahmud H, Khayrani AC, et al. Use of DNA-generated gold nanoparticles to radiosensitize and eradicate radioresistant glioma stem cells. Nanotechnology. 2019;30(5):055101.","journal-title":"Nanotechnology"},{"key":"2164_CR223","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/pharmaceutics17020176","volume":"17","author":"GG Carbone","year":"2025","unstructured":"Carbone GG, Mariano S, Gabriele A, Cennamo S, Primiceri V, Aziz MR, et al. Exploring the Potential of Gold Nanoparticles in Proton Therapy: Mechanisms, Advances, and Clinical Horizons. Pharmaceutics. 2025;17:176.","journal-title":"Pharmaceutics"},{"key":"2164_CR224","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.3390\/ijms22189673","volume":"22","author":"H Ruiz-Garcia","year":"2021","unstructured":"Ruiz-Garcia H, Ramirez-Loera C, Malouff TD, Seneviratne DS, Palmer JD, Trifiletti DM. Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma. Int J Mol Sci. 2021;22:9673.","journal-title":"Int J Mol Sci"},{"issue":"824","key":"2164_CR225","doi-asserted-by":"publisher","first-page":"eadq6645","DOI":"10.1126\/scitranslmed.adq6645","volume":"17","author":"CC Wu","year":"2025","unstructured":"Wu CC, Szalontay L, Pouliopoulos AN, Bae S, Berg X, Wei HJ, et al. Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma. Science Translational Medicine. 2025;17(824):eadq6645.","journal-title":"Science Translational Medicine"},{"key":"2164_CR226","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/pharmaceutics14102231","volume":"14","author":"A Barzegar-Fallah","year":"2022","unstructured":"Barzegar-Fallah A, Gandhi K, Rizwan SB, Slatter TL, Reynolds JNJ. Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood-Brain Tumour Barrier. Pharmaceutics. 2022;14:2231.","journal-title":"Pharmaceutics"},{"key":"2164_CR227","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ddtec.2016.07.007","volume":"20","author":"A Dasgupta","year":"2016","unstructured":"Dasgupta A, Liu M, Ojha T, Storm G, Kiessling F, Lammers T. Ultrasound-mediated drug delivery to the brain: principles, progress and prospects. Drug Discov Today Technol. 2016;20:41\u201348.","journal-title":"Drug Discov Today Technol"},{"key":"2164_CR228","doi-asserted-by":"publisher","first-page":"119325","DOI":"10.1016\/j.biopha.2026.119325","volume":"198","author":"W ElNemer","year":"2026","unstructured":"ElNemer W, Lee D, Selim O, Slika H, Farias AS, Suvarnapathaki S, et al. Focused ultrasound mediated gene therapy for glioblastoma: A preclinical in vivo systematic review and meta-analysis. Biomed Pharmacother. 2026;198:119325.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2164_CR229","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","volume":"24","author":"AM Sonabend","year":"2023","unstructured":"Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, et al. Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. The Lancet Oncology. 2023;24(5):509\u201322.","journal-title":"The Lancet Oncology"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02164-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02164-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02164-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:03:15Z","timestamp":1788357795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02164-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":229,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02164-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not include studies with human or animal participants, performed by any of the authors.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}